Get startedLog in
    Picture of HLS Therapeutics logo

    HLS — HLS Therapeutics News Story

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareBalancedSmall CapNeutral
    All News

    Brief: Vascepa Found To Significantly Reduce Ischemic Events In Patients With Prior Coronary Artery Bypass Grafting Procedures

    Picture of HLS Therapeutics logoHLS Therapeutics
    16/11/2020 12:09
    Nov 16 (Reuters) - HLS Therapeutics Inc  HLS.TO :
    * VASCEPA® (ICOSAPENT ETHYL) FOUND TO SIGNIFICANTLY REDUCE
ISCHEMIC EVENTS IN PATIENTS WITH PRIOR CORONARY ARTERY BYPASS
GRAFTING PROCEDURES

Source text for Eikon:  ID:nCNWyxhx6a 
Further company coverage:  HLS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on HLS Therapeutics

    See all news